Rho Capital Partners’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Hold
0
7
2021
Q3
Sell
-41,641
Closed -$21.4M 7
2021
Q2
$21.4M Sell
41,641
-29,166
-41% -$15M 1.96% 4
2021
Q1
$55.3M Sell
70,807
-6,945
-9% -$5.43M 5.32% 4
2020
Q4
$42.4M Hold
77,752
22.29% 2
2020
Q3
$35.6M Hold
77,752
29.66% 2
2020
Q2
$47.9M Sell
77,752
-10,944
-12% -$6.74M 31% 2
2020
Q1
$42.2M Hold
88,696
42.5% 2
2019
Q4
$51.4M Hold
88,696
39.1% 2
2019
Q3
$58.4M Sell
88,696
-2,083
-2% -$1.37M 48.88% 1
2019
Q2
$70.3M Sell
90,779
-8,334
-8% -$6.45M 48.74% 1
2019
Q1
$70M Hold
99,113
74.08% 1
2018
Q4
$46.4M Hold
99,113
68.07% 1
2018
Q3
$85.5M Hold
99,113
78.61% 1
2018
Q2
$68.3M Hold
99,113
65.36% 1
2018
Q1
$44.2M Hold
99,113
62.3% 1
2017
Q4
$43.7M Hold
99,113
75.9% 1
2017
Q3
$48.8M Hold
99,113
76.92% 1
2017
Q2
$54.9M Hold
99,113
76.67% 1
2017
Q1
$65.6M Buy
99,113
+13,889
+16% +$9.2M 92.21% 1
2016
Q4
$28.5M Hold
85,224
21.84% 2
2016
Q3
$25.6M Hold
85,224
17.3% 3
2016
Q2
$14.8M Hold
85,224
11.8% 4
2016
Q1
$19.1M Buy
85,224
+11,111
+15% +$2.49M 10.45% 5
2015
Q4
$45M Hold
74,113
15.47% 3
2015
Q3
$38.1M Hold
74,113
12.66% 3
2015
Q2
$32.4M Hold
74,113
11.33% 4
2015
Q1
$26.8M Hold
74,113
11.18% 4
2014
Q4
$26.6M Hold
74,113
11.8% 4
2014
Q3
$22.4M Hold
74,113
11.24% 4
2014
Q2
$45.4M Hold
74,113
17.64% 3
2014
Q1
$49.7M Buy
+74,113
New +$49.7M 19.38% 3